A detailed history of Advisor Group Holdings, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 5,235 shares of CRL stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,235
Previous 5,917 11.53%
Holding current value
$1.04 Million
Previous $1.22 Million 15.63%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$187.96 - $245.29 $128,188 - $167,287
-682 Reduced 11.53%
5,235 $1.03 Million
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $91,843 - $119,584
445 Added 8.13%
5,917 $1.22 Million
Q1 2024

May 10, 2024

SELL
$203.52 - $273.43 $3.53 Million - $4.75 Million
-17,365 Reduced 76.04%
5,472 $1.48 Million
Q4 2023

Feb 12, 2024

SELL
$164.52 - $238.84 $2.12 Million - $3.08 Million
-12,882 Reduced 36.06%
22,837 $5.4 Million
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $2.19 Million - $2.45 Million
11,246 Added 45.95%
35,719 $7 Million
Q2 2023

Aug 10, 2023

SELL
$183.71 - $210.25 $448,068 - $512,799
-2,439 Reduced 9.06%
24,473 $5.15 Million
Q1 2023

May 12, 2023

SELL
$191.89 - $259.92 $46,245 - $62,640
-241 Reduced 0.89%
26,912 $5.43 Million
Q4 2022

Feb 10, 2023

SELL
$197.11 - $250.07 $244,416 - $310,086
-1,240 Reduced 4.37%
27,153 $5.91 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $1.23 Million - $1.68 Million
-6,720 Reduced 19.14%
28,393 $5.59 Million
Q2 2022

Aug 10, 2022

SELL
$204.13 - $302.4 $687,713 - $1.02 Million
-3,369 Reduced 8.75%
35,113 $7.51 Million
Q1 2022

May 04, 2022

BUY
$255.51 - $362.11 $2.24 Million - $3.17 Million
8,750 Added 29.43%
38,482 $14.2 Million
Q3 2021

Nov 05, 2021

BUY
$372.64 - $458.3 $2.14 Million - $2.63 Million
5,735 Added 23.9%
29,732 $12.3 Million
Q2 2021

Aug 02, 2021

BUY
$294.17 - $371.65 $1.41 Million - $1.78 Million
4,796 Added 24.98%
23,997 $8.88 Million
Q1 2021

May 13, 2021

BUY
$249.67 - $299.48 $431,679 - $517,800
1,729 Added 9.9%
19,201 $5.57 Million
Q4 2020

Feb 10, 2021

BUY
$222.0 - $252.62 $490,176 - $557,784
2,208 Added 14.47%
17,472 $4.36 Million
Q3 2020

Nov 12, 2020

BUY
$175.56 - $226.45 $279,140 - $360,055
1,590 Added 11.63%
15,264 $3.41 Million
Q2 2020

Aug 14, 2020

BUY
$118.84 - $189.72 $225,082 - $359,329
1,894 Added 16.08%
13,674 $2.39 Million
Q1 2020

May 18, 2020

BUY
$98.9 - $178.34 $1.17 Million - $2.1 Million
11,780 New
11,780 $1.49 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.